Edition:
United Kingdom

Rocky Swift

Japan's small clinics driven to brink as virus-wary patients stay home

25 May 2020

TOKYO As Japan eases coronavirus curbs following its first wave of cases, many small medical clinics are scrambling to stay afloat and the doctors who run them are calling for government support as patients keep away for fear of infection.

Japan's regions emerge from virus emergency while Tokyo enters 'new normal'

15 May 2020

TOKYO Large parts of Japan marked the first day out of a state of emergency on Friday while Tokyo's governor asked residents to prepare for the "new normal" as restrictions stay in place in the capital and major cities. | Video

Japan's regions, companies emerge from virus emergency while Tokyo restrictions remain

15 May 2020

TOKYO, May 15 Large parts of Japan marked the first day out of a state of emergency on Friday while major cities remained under coronavirus restrictions and new testing suggested that contagion in Tokyo was wider than official figures.

A tale of two Japanese drugs in tests to fight COVID-19

15 May 2020

(This May 13 story corrects to remove reference to University of Kentucky trial in penultimate paragraph)

Part of Gilead's coronavirus drug donation allocated to Japan

14 May 2020

TOKYO Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's coronavirus drug remdesivir, days after granting emergency approval to the medication the company is supplying as part of its pledged donation.

Parte de la donación de medicamentos de Gilead será destinada a Japón

14 May 2020

TOKIO, 14 mayo Japón ha comenzado a tratar a los pacientes gravemente enfermos de COVID-19 con el medicamento remdesivir de Gilead Sciences Inc, días después de que otorgó una autorización de emergencia para el fármaco que la compañía está entregando como parte de su donación comprometida.

Japón dice que está tratando pacientes graves de COVID-19 con redemsivir

14 May 2020

TOKIO, 14 may Japón ha comenzado a tratar a los pacientes gravemente enfermos de COVID-19 con el medicamento remdesivir de Gilead Sciences Inc COVID-19, dijo un alto cargo del Ministerio de Sanidad, sólo unos días después de dar la aprobación de emergencia del medicamento con la intención de frenar el brote de coronavirus.

Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

14 May 2020

TOKYO, May 14 Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it seeks to curb the coronavirus outbreak.

Takeda Pharma logs surprise profit, updates on COVID-19 therapy

13 May 2020

TOKYO/NEW YORK Takeda Pharmaceutical Co booked a surprise operating profit and forecast that income would triple this business year as hefty acquisition costs related to last year's $59 billion Shire takeover recede.

World News

Tensions rise in U.S. cities after police shot; Trump pushes crackdown

President Donald Trump on Tuesday taunted state governors for not embracing his proposal to send in the U.S. military to quell unrest, hours after five officers were shot and wounded in an escalation of tensions between law enforcement and crowds protesting the killing of a black man in police custody.